Search Results

Displaying Results 5576-5600 of 7004 "'MASS'"

Dec 12, 2025, 11:07 ET BTDR DEADLINE: Faruqi & Faruqi Reminds Bitdeer Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 2, 2026 - BTDR

failed to disclose that the SEAL04 chip projected to have a chip-level energy efficiency of 5 J/TH would be ready for use in the A4 rigs with an expected mass production to begin in the second quarter 2025.On November 10, 2025, Bitdeer issued a press release reporting its unaudited financial results

More news about: Faruqi & Faruqi, LLP


Dec 12, 2025, 09:49 ET AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs

multimedia:https://www.prnewswire.com/news-releases/ai-diagnostics-hit-critical-mass-as-hospitals-race-to-cut-costs-302640231.html

More news about: USA News Group


Dec 12, 2025, 09:00 ET Raise Network Selects Solana as Infrastructure Partner to Power A New On-Chain Gift Card and Loyalty Ecosystem

https://www.raise.com/.About SolanaSolana is a blockchain built for mass adoption. It's a high performance network that is utilized for a range of use cases, including finance, NFTs, payments, and gaming. Solana

More news about: Raise


Dec 12, 2025, 07:00 ET Insilico Medicine and TaiGen Achieves License Agreement to Develop and Commercialize AI-driven PHD Inhibitor for Anemia of Chronic Kidney Disease (CKD)

accelerate the development of ISM4808 for the treatment of Anemia of Chronic Kidney Disease (CKD).CAMBRIDGE, Mass., Dec. 12, 2025 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence

More news about: Insilico Medicine


Dec 12, 2025, 07:00 ET Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study, STARt-002, at the 2025 San Antonio Breast Cancer Symposium

phase 2 expansion cohorts currently enrolling at select North American cancer centersCAMBRIDGE, Mass., Dec. 12, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering

More news about: Marengo Therapeutics


Dec 12, 2025, 04:55 ET Home Decor Market to Surpass USD 880B by 2030 as DIY & Mass Merchandisers are Set to Grow as the Fastest Distribution Channel, Reports Mordor Intelligence

Distribution Channel Specialty Stores DIY / Mass Merchandiser Online / E-commerce Interior Designers and Contractors By Price Tier Mass / Value Premium Luxury / Designer By Geography 

More news about: Mordor Intelligence Private Limited


Dec 12, 2025, 02:30 ET Sunwoda's 314Ah Cell is Now the World's First Battery Product Certified by EPD International

Sunwoda's energy storage cell portfolio, the 314Ah cell is renowned for its outstanding safety, high energy density and ultra-long cycle life. Since mass production, it has earned strong recognition from customers worldwide and helped propel Sunwoda into the Top 10 for global energy storage cell shipments

More news about: Sunwoda


Dec 11, 2025, 19:19 ET BTDR Investors Have Opportunity to Lead Bitdeer Technologies Group Securities Fraud Lawsuit

technology roadmap for its SEALMINER Bitcoin mining machine. Defendants' statements included, among other things, confidence in Bitdeer's mass production of its fourth-generation SEALMINER (A4) rigs using its SEAL04 ASIC ("application-specific integrated circuit") chip technology

More news about: THE ROSEN LAW FIRM, P. A.


Dec 11, 2025, 19:00 ET Mazdutide Demonstrates Significant Weight Loss and Metabolic Benefits in Phase 1b Clinical Trial in Chinese Adolescents with Obesity

All participants had undergone dietary and exercise intervention for at least 12 weeks prior to enrollment but achieved less than 5% reduction in body mass index (BMI). The participants met the obesity criteria specified in the Chinese national standard "WS/T 586‑2018 Screening for Overweight and Obesity

More news about: Innovent Biologics


Dec 11, 2025, 18:06 ET Berger Montague PC Investigates Warner Bros. Discovery, Inc.'s Board of Directors for Breach of Fiduciary Duty (NASDAQ: WBD)

CLICKING HERE.Warner Bros., headquartered in New York City, is a multinational mass-media and entertainment conglomerate, operating in film and TV studios, streaming services, and cable/linear networks.Berger Montague

More news about: Berger Montague


Dec 11, 2025, 16:04 ET FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial

dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce that the Sean M. Healey & AMG Center for ALS at Mass General Brigham has received clearance from the US Food and Drug Administration (FDA) to proceed with Neurizon's NUZ-001 regimen in the HEALEY ALS Platform

More news about: Neurizon Therapeutics Limited


Dec 11, 2025, 15:49 ET FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial

dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce that the Sean M. Healey & AMG Center for ALS at Mass General Brigham has received clearance from the US Food and Drug Administration (FDA) to proceed with Neurizon's NUZ-001 regimen in the HEALEY ALS Platform

More news about: Neurizon Therapeutics Limited


Dec 11, 2025, 13:07 ET Veteran Ventures Capital Announces Investment in Vatn Systems, Supporting a New Era of Scalable Undersea Autonomy

innovation VVC was created to support," said Derren Burrell, Founder and Managing Partner of Veteran Ventures Capital. "Their team is fielding the undersea mass our national security enterprise urgently needs, and they're doing it with a level of technical rigor and operational intuition that's rare in this

More news about: Veteran Ventures Capital


Dec 11, 2025, 13:06 ET Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Access Partnership to China

NATICK, Mass., Dec. 8, 2025 /PRNewswire/ -- Pillar Biosciences announced today an expansion of its existing laboratory access program with AstraZeneca for NGS-based kitted liquid biopsy tumor profiling to include China.

More news about: Pillar Biosciences, Inc.


Dec 11, 2025, 11:38 ET Rivergate Marketing Enhances Consulting Offerings With GTM Strategy Workshops

Go-to-Market Strategy Workshops for system integrators and industrial automation companies.ARLINGTON, Mass., Dec. 11, 2025 /PRNewswire/ -- 

More news about: Rivergate Marketing


Dec 11, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Cepton, Inc. and Certain Officers - CPTN

("Koito") (the "Koito Acquisition" or the "Merger") (as described below), Cepton was an electronics company focused on the deployment of high performance, mass-market light detection and ranging ("lidar") technologies to deliver safety and autonomy across the Automotive and Smart Infrastructure markets.  The

More news about: Pomerantz LLP


Dec 11, 2025, 09:30 ET Mitsubishi Chemical Group and Boston Materials Form Strategic Collaboration to Advance Semiconductor Packaging with Breakthrough Liquid Metal Thermal Materials

BILLERICA, Mass., Dec. 11, 2025 /PRNewswire/ -- Mitsubishi Chemical Group (MCG), a leading global provider of advanced materials, and Boston Materials, Inc., a manufacturer of advanced energy transfer materials, today announced

More news about: Boston Materials


Dec 11, 2025, 09:15 ET ETQ Ranked as Front Runner in LNS Research Enterprise Quality Management Software Solution Selection Matrix 2025

ETQ Recognized as 'More Advanced Software Provider' in EQMS SpaceBURLINGTON, Mass., Dec. 11, 2025 /PRNewswire/ --

More news about: ETQ, LLC


Dec 11, 2025, 09:00 ET Cellid and Jig.jp Jointly Develop AR Glasses

will jointly develop AR glasses equipped with Cellid's plastic waveguides (AR glass lenses) – the only domestically mass-produced version – for the Sabae-designed AR glasses being developed and sold by jig.jp Inc. (Headquarters: Sabae City,

More news about: Cellid, Inc.


Dec 11, 2025, 09:00 ET Five Leading Cancer Centers Unite to Target CD123 and Eradicate Hidden Leukemia Cells

next-generation MRD testing to track residual disease and uncover vulnerabilities in leukemia cellsCAMBRIDGE, Mass., Dec. 11, 2025 /PRNewswire/ -- Acute myeloid leukemia (AML) is an aggressive blood cancer, with overall survival

More news about: Break Through Cancer


Dec 11, 2025, 08:54 ET DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025

(267)764-4865.About Berger MontagueBerger Montague is one of the nation's preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader

More news about: Berger Montague


Dec 11, 2025, 08:52 ET K2 Space Raises $250M at $3B Valuation to Roll Out a New Class of High-Capability Satellites

science fiction:AI scale compute on orbitHigh-throughput networks spanning orbits – and planetsMass-produced giant telescopes to vastly expand scientific return from across the solar system and beyond"Our north star is simple," said

More news about: K2 Space


Dec 11, 2025, 08:34 ET SHOPLINE Partners with LaunchBoom to Power Seamless Crowdfunding-to-E-Commerce Growth for Product Creators

GrowthLaunchBoom has helped more than a thousand creators validate products, sell their first 3,000+ units, and generate six to seven-figure pre-sales before mass production. By pairing that early traction with SHOPLINE's powerful commerce infrastructure, creators can now move from launch to long-term scale with

More news about: SHOPLINE


Dec 11, 2025, 08:30 ET Fescaro sees rising demand for automotive cybersecurity solutions

entire 15-year lifecycle of these keys, ensuring that only authorized users have control permissions.As cybersecurity becomes a prerequisite for mass production, automakers are increasingly requiring ECU developers to integrate KMS into their manufacturing lines. With around 100 million vehicles produced

More news about: The Korea Herald


Dec 11, 2025, 08:30 ET WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS

Calling for Greater Education, Testing, and Prevention of In Vitro Hemolysis in High-Risk SettingsBEDFORD, Mass., Dec. 11, 2025 /PRNewswire/ -- Werfen today announced their commendation for the recent publication of a significant,

More news about: Werfen


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.